Methylphenidate ER
Solicitation from Department of Defense.
Data as of Oct 24, 2026. Sources: SAM.gov and Grants.gov. Snapshot govcon-directory-20261024T104923Z-2151694.
This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services. Counts and totals are computed by DSE from public SAM.gov and Grants.gov notices. Text from Grants.gov may be shortened or have contact details removed. The original notice on Grants.gov is the authoritative version.
Closing in 13 days
Notice details
- Agency
- Department of Defense
- Sub-tier agency
- DEFENSE LOGISTICS AGENCY
- Notice type
- Solicitation
- Solicitation number
- SPE2D226R0013
- Product/service code
- 6505
- Posted
- Oct 22, 2026
- Response deadline
- Nov 6, 2026
- Source
- SAM.gov
Description
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Methylphenidate ER Tablets. Procurement details follow. Methylphenidate ER 18MG, 27MG, 36MG, and 54MG Tablets in 100 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of War, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact contact details on the official notice at [contact details on the official notice], ([contact details on the official notice]) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected
Summarized from the official notice. The description is shortened; read the full text on the official notice.
Official notice
Requirements and amendments are controlled by the official notice.
DSE verdict
The DSE fit verdict for this notice is available to DSE GovCon subscribers. It is not published on this page.
See DSE GovCon plans →Similar open notices
- Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount ProgramClosing in 2 days
- Epinephrine InjectorClosing in 23 days
- Morphine Sulfate SolutionOpen, no deadline stated
- Bicalutamide TabletsOpen, no deadline stated
- Dapagliflozin TabletsOpen, no deadline stated
Get free alerts
Email alerts for notices like this one are free on DSE GovCon Intelligence.
Set up free alerts →Frequently asked questions
When is the response deadline?
The published deadline is Nov 6, 2026. That is 13 days after the data date.
What NAICS code applies?
NAICS 325412, Pharmaceutical Preparation Manufacturing.
Which agency issued this notice?
Department of Defense.
Where is the official notice?
The link under Official notice opens the source listing.